AstraZeneca

Focus: Rare diseases- Hereditary Transthyretin amyloidosis (ATTR)

AstraZeneca is a science-led biopharmaceutical company pushing the boundaries of science to deliver life-changing medicines in Rare Diseases, Oncology, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.

Pharmaceutical Companies